Ali Aytuğ KUŞTAŞ

Ali Aytuğ KUŞTAŞ

Auto-generated profile, based on publicly available information

Ali Aytuğ KUŞTAŞ


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2020 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
EAErman Akkus
Erman Akkus
ÇFÇiğdem Fi̇dan
Çiğdem Fi̇dan
GDGülşah Demi̇rci̇
Gülşah Demi̇rci̇
AKAli Aytuğ KUŞTAŞ
Ali Aytuğ KUŞTAŞ
MYMeltem Kurt Yüksel
Meltem Kurt Yüksel
Immune thrombocytopenia (ITP) is treated by corticosteroids and/or intravenous immune globulin as the first line treatment when necessary. Mean platelet volume (MPV) is a marker of platelet production and function. In this study, we aimed to search the relationship between the MPV and the treatment response in ITP patients and it was hypothesized that MPV can be used as a predictor of the response. The seventy newly diagnosed adult primary ITP patients and seventy of healthy people were included. MPV between ITP and healthy population, MPV in the diagnosis and after the treatment between the responders and the non-responders were compared. The responders had significantly higher MPV and the non-responders had significantly lower MPV than the healthy population (11.09 and 10.21 fL, P = 0.03; 9.38 and 10.21 fL, P = 0.001). MPV in the diagnosis was significantly higher in the responders than the non-responders (11.09 and 9.38 fL, P = 0.005). MPV significantly changed after the treatment in the responders (11.09 to 9.32 fL, P = 0,004). MPV can be used as a predictor of early response to the first line treatment in newly diagnosed adult primary ITP patients.